Antonio Casado

14.5k total citations · 2 hit papers
178 papers, 5.7k citations indexed

About

Antonio Casado is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Reproductive Medicine. According to data from OpenAlex, Antonio Casado has authored 178 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Oncology, 65 papers in Pulmonary and Respiratory Medicine and 60 papers in Reproductive Medicine. Recurrent topics in Antonio Casado's work include Ovarian cancer diagnosis and treatment (57 papers), Sarcoma Diagnosis and Treatment (35 papers) and Endometrial and Cervical Cancer Treatments (29 papers). Antonio Casado is often cited by papers focused on Ovarian cancer diagnosis and treatment (57 papers), Sarcoma Diagnosis and Treatment (35 papers) and Endometrial and Cervical Cancer Treatments (29 papers). Antonio Casado collaborates with scholars based in Spain, United States and United Kingdom. Antonio Casado's co-authors include Ignace Vergote, Frédéric Amant, Tom Ehlen, Gunnar B. Kristensen, N.S. Reed, Corneel Coens, Gemma G. Kenter, Gavin Stuart, Nick Johnson and René H.M. Verheijen and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Antonio Casado

174 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

2010 1.7k citations Ignace Vergote, Claes G. Tropé et al. profile →
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer

2020 359 citations Vicky Makker, Matthew H. Taylor et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Antonio Casado

Since Specialization

Citations

This map shows the geographic impact of Antonio Casado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonio Casado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonio Casado more than expected).

Fields of papers citing papers by Antonio Casado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonio Casado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonio Casado. The network helps show where Antonio Casado may publish in the future.

Co-authorship network of co-authors of Antonio Casado

This figure shows the co-authorship network connecting the top 25 collaborators of Antonio Casado. A scholar is included among the top collaborators of Antonio Casado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonio Casado. Antonio Casado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary results and characterization of patients with exceptional outcomes in a phase 1b study combining PARP and MEK inhibition, with or without anti–PD‐L1, for BRCA wild‐type, platinum‐sensitive, recurrent ovarian cancer 2024 ·Cancer ·David G. Mutch, Athina Voulgari, Xian Chen, William H. Bradley, Ana Oaknin, José Alejandro Pérez Fidalgo, (unknown), Antonio Casado, Robert W. Holloway, Matthew A. Powell, Małgorzata Nowicka, Gabriele Schaefer, Mark Merchant, Yibing Yan	2
2	Cost-effectiveness of olaparib plus bevacizumab versus bevacizumab monotherapy in the maintenance of patients with homologous recombination deficiency-positive advanced ovarian cancer after response to first-line platinum-based chemotherapy 2023 ·International Journal of Gynecological Cancer ·(unknown), (unknown), (unknown), Luís Manso, (unknown), (unknown), Antonio Casado, José Alejandro Pérez Fidalgo	1
3	1926P Trabectedin plus radiotherapy on symptomatic advanced sarcoma patients: Results from the SYNERGIAS study - A Spanish group for research in sarcoma (GEIS) phase II study 2023 ·Annals of Oncology ·Javier Martín‐Broto, Kateřina Kopečková, Ignacio Azinovic, Josefina Cruz Jurado, Lorena Guzmán, Rosa Álvarez, Antonio Casado, (unknown), Andrés Redondo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Ramiro Méndez, (unknown), Antonio Gutiérrez, David S. Moura, (unknown)	1
4	Immunogenicity and clinical activity of tipapkinogen sovacivec (TG4001), an HPV-16 cancer vaccine: A randomized phase 2 study in advanced anogenital cancers. 2023 ·Journal of Clinical Oncology ·Christophe Le Tourneau, Frédéric Rolland, Olivier Capitain, Amaury Daste, Philippe A. Cassier, Sébastien Salas, Luís Manso, Antonio Casado, Gerardo Colón‐Otero, Lauriane Eberst, (unknown), Ana I. Lalanne, Olivier Lantz, (unknown), Annette Tavernaro, Kaïdre Bendjama, (unknown), Jean‐Pierre Delord	0
5	2022-RA-653-ESGO The impact of histology, prior therapy, and dMMR status on lenvatinib + pembrolizumab outcomes in patients with advanced endometrial cancer: A subgroup analysis of Study 309/KEYNOTE-775 2022 ·International Journal of Gynecological Cancer ·Domenica Lorusso, Vicky Makker, Antonio Casado, Bradley J. Monk, Helen Mackay, Alessandro D. Santin, David S. Miller, Richard G. Moore, Sally Baron‐Hay, Isabelle Ray‐Coquard, Ronnie Shapira‐Frommer, Kimio Ushijima, Kan Yonemori, Yong Man Kim, Eva María Guerra Alia, Ulus Ali Şanlı, (unknown), Jodi A. McKenzie, (unknown), Nicoletta Colombo	1
6	Complete Spontaneous Regression of Lung Metastases after Resection of CIC-Rearranged Sarcoma: A Case Report 2021 ·Case Reports in Oncology ·Gloria Marquina, Silvia Sánchez‐Ramón, (unknown), Luís Ortega, Ana Bustos, Florentino Hernándo, (unknown), Antonio Casado	2
7	Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer breakdown → 2020 ·Journal of Clinical Oncology ·Vicky Makker, Matthew H. Taylor, Carol Aghajanian, Ana Oaknin, James W. Mier, Allen Lee Cohn, Margarita Romeo, Raquel Bratos, Marcia S. Brose, Christopher DiSimone, Mark Messing, Daniel E. Stepan, Corina E. Dutcus, Jane Wu, Emmett V. Schmidt, Robert Orlowski, Perminder S. Sachdev, Robert Shumaker, Antonio Casado	359
8	Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol 2020 ·Cancers ·(unknown), Marco Fiore, Javier Martín‐Broto, Bernd Kasper, Antonio Casado, Dagmara Kuliś, Ioanna Nixon, Samantha C. Sodergren, Martin Eichler, Winan J. van Houdt, Ingrid M.E. Desar, Isabelle Ray‐Coquard, Claire Piccinin, Hanna Koseła-Paterczyk, Aisha Miah, Leopold Hentschel, Susanne Singer, Roger Wilson, Winette T.A. van der Graaf, Olga Husson	22
9	Neoadjuvant Chemotherapy Versus Debulking Surgery in Advanced Tubo-Ovarian Cancers: Pooled Analysis of Individual Patient Data From the EORTC 55971 and CHORUS Trials 2019 ·Obstetrical & Gynecological Survey ·Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B. Kristensen, Mahesh Parmar, Tom Ehlen, Gordon C. Jayson, Nick Johnson, (unknown), René H.M. Verheijen, W. Glenn McCluggage, Timothy Perren, Pierluigi Benedetti Panici, Gemma G. Kenter, Antonio Casado, César Mendiola, Gavin Stuart, N.S. Reed, Sean Kehoe	30
10	SEOM clinical guidelines in gestational trophoblastic disease (2017) 2017 ·Clinical & Translational Oncology ·Ana Santaballa, Yolanda García García, Ana Herrero, Núria Laínez, (unknown), (unknown), (unknown), Jorge Aparicio, Antonio Casado, (unknown)	28
11	SCHISTOSOMUS REFLEXUS EN UN CANINO: REPORTE CASO 2012 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Antonio Casado, (unknown)	2
12	Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study 2011 ·Journal of Clinical Oncology ·Xavier García del Muro, Antonio López–Pousa, Joan Maurel, Javier Martín‐Broto, Javier Martínez‐Trufero, Antonio Casado, Auxiliadora Gómez‐España, J. Fra, Josefina Cruz, Andrés Poveda, Andrés Meana, Carles Pericay, Ricardo Cubedo, Jordi Rubió‐Casadevall, Ana De Juan, Núria Laínez, Juan Antonio Carrasco, (unknown), J. Buesa	197
13	European Network of Gynaecological Oncological Trial Groups’ Requirements for Trials Between Academic Groups and Pharmaceutical Companies 2010 ·International Journal of Gynecological Cancer ·Ignace Vergote, Éric Pujade-Lauraine, Sandro Pignata, Gunnar B. Kristensen, Jonathan A. Ledermann, Antonio Casado, Jalid Sehouli, Mansoor Raza Mirza, Roldano Fossati, Christian Marth, Carien L. Creutzberg, (unknown), (unknown), Paula Calvert, A. Bamias, Gökhan Tulunay, (unknown), Andreas du Bois	13
14	A Phase II Trial of Fixed-Dosed Rate Gemcitabine in Platinum-Resistant Ovarian Cancer 2008 ·American Journal of Clinical Oncology ·(unknown), Antonio González-Martı́n, (unknown), Xavier Mayol, Begoña Mellado, M.J. Rubio Pérez, Lorenzo Alonso-Carrión, Antonio Casado, E. Calvo García, (unknown), Angels Arcusa Lanza, (unknown), (unknown), A. Poveda Velasco	7
15	Bevacizumab in Combination with Metronomic Chemotherapy in Patients with Anthracycline- and Taxane-Refractory Breast Cancer 2008 ·Journal of Chemotherapy ·José Á. García-Sáenz, Miguel Martín, Antonio Calles, Coralia Bueno, (unknown), (unknown), Ana Custodio, Antonio Casado, Eduardo Díaz‐Rubio	50
16	Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer 2007 ·Cancer ·Christian Marth, Joan L. Walker, Richard R. Barakat, Antonio Casado, Angiolo Gadducci, Brigitte Miller, Franco Odicino, Eric Pujade‐Lauraine, Jalid Sehouli, Claes G. Tropé, Lari Wenzel, Alain G. Zeimet	23
17	Sarcomas de partes blandas y de los huesos 2006 ·Coralia Bueno, (unknown), Antonio Casado	1
18	Phase II Trial of Doxorubicin Plus Escalated High‐Dose Ifosfamide in Patients With Advanced Soft Tissue Sarcomas of the Adult: A Study of the Spanish Group for Research on Sarcomas (GEIS) 2006 ·Sarcoma ·Antonio López–Pousa, Javier Martín‐Broto, Joaquín Montalar, R. de las Peñas, Javier García del Muro, Juan Jesús Cruz, Joan Maurel, P. Escudero, Antonio Casado, J. Buesa	4
19	Integration of new or experimental treatment options and new approaches to clinical trials 2005 ·Annals of Oncology ·Michael Quinn, Jacobus Pfisterer, (unknown), Michael A. Bookman, David D.L. Bowtell, Antonio Casado, Andrés Cervantes, Seija Grénman, (unknown), Amit M. Oza, S. Pecorelli, Éric Pujade-Lauraine, Edward L. Trimble, P. Vasey, Uwe Wagner	2
20	Quimioterapia de los sarcomas de partes blandas 2004 ·(unknown), Antonio Casado	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact